Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion.
Introduction
Pancreatic cancer is the fourth leading cause of cancer-related death in western societies. The overall 5-year survival rate among pancreatic cancer patients is less than 3% and the median survival is less than 6 months [1] [2] [3] . As the cancer-specific symptoms present only at a late stage, the majority of pancreatic cancer patients already have an advanced stage disease at the time of diagnosis. There is an urgent need to identify novel therapeutic approaches and, most importantly, early detection of the disease to improve the survival of patients with pancreatic cancer.
The majority of pancreatic cancer patients present with either new-onset type 2 diabetes or impaired glucose tolerance at the time of diagnosis 4, 5 . Epidemiological studies have reported both obesity and type 2 diabetes to be among the top three modifiable risk factors for pancreatic cancer [6] [7] [8] [9] . In addition, among the cases with resectable pancreatic cancer, the majority of patients show improved insulin sensitivity after tumour resection, although a large part of the pancreas is removed 10 . Despite a strong link between the two diseases, the relationship between type 2 diabetes and pancreatic cancer is complex and largely unknown.
It remains to be elucidated if the microenvironment in type 2 diabetes is favourable for the development of pancreatic cancer or if cancer cells at an early stage give rise to the diabetes.
Chronic inflammatory conditions increase the risk of different forms of cancer. Patients with chronic pancreatitis have an increased risk of developing pancreatic cancer 11 . Both type 2 diabetes and pancreatic cancer are associated with elevated local and systemic low grade inflammation, which is believed to influence the pathogenesis of both diseases [12] [13] [14] .
Inflammation plays a central role in the tumour microenvironment and has recently been acknowledged as a novel hallmark of cancer due to its association with the pathogenesis in many types of cancer [14] [15] [16] . Macrophages are believed to play a major role in orchestrating the cancer-related inflammation and have commonly been divided into two classes; M1
"classically activated, pro-inflammatory" macrophages and M2 "alternatively activated" macrophages 17 . Macrophages originate from blood monocytes being recruited to the tissue where they are activated. Stimulation with LPS and IFNγ leads to M1 activation and the secretion of IL-1β, IL-6 and TNFα along with the expression of HLA-DR hi and CD11c, among others. M2 macrophages in contrast, are activated by IL-4 and IL-13, secrete IL-10
and express markers such as HLA-DR lo and CD206 (mannose receptor). M1-macrophages have been observed in type 2 diabetes infiltrating adipose tissue and pancreatic islets, and are believed to play a central role in the diabetes-associated inflammation through IL-1 and NFκB activation 12 . Tumour-associated macrophages (TAMs), on the other hand, display a M2-like phenotype and are characterised by CD206 + as well as arginase 1 (Arg1) expression, and the secretion of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), IL-6, IL-10, and matrix metalloproteinases (MMPs). TAMs promote carcinogenesis by stimulating angiogenesis, migration, invasion, metastasis and ECM remodelling [14] [15] [16] [18] [19] [20] [21] . However, recent reviews on TAMs demonstrate that the M1-M2 classification might be over-simplified and no longer sufficient, with intermediate phenotypes emerging due to the plasticity of macrophages, enabling them to adjust to their specific microenvironment [18] [19] [20] [21] .
Metformin is used as first-line treatment in the management of type 2 diabetes. The key metabolic action of metformin involves the inhibition of hepatic glucose secretion. This mechanism is mediated via activation of the energy-sensing AMP-activated protein kinase (AMPK) in hepatocytes 22 . In addition to its anti-diabetic effects, metformin has recently been shown to possess anti-tumour effects, both in AMPK-dependent and independent manners 23 .
Metformin has also been indicated to have anti-inflammatory effects by indirectly inhibit LPS response and/or NFκB-signalling 24, 25 .
Although inflammation has an established role in carcinogenesis, limited research has been performed in pancreatic cancer and the influence by related type 2 diabetes. The aim of the present study was to investigate the interplay between tumour cells and immune cells under the influence of different glucose levels. Tumour cell-induced macrophage enrichment, phenotype polarisation and associated cytokine secretion was analysed in vitro. Furthermore, pro-tumour properties on pancreatic cancer cell invasion by tumour-educated macrophages were investigated, as well as the anti-inflammatory properties of metformin.
Results

Hyperglycaemia enhances pancreatic cancer cell-stimulated macrophage differentiation and cytokine secretion
Given the important pleiotropic roles of macrophages in tumour progression and T2D, we sought to establish the influence by pancreatic cancer cells and glucose levels on monocyte to macrophage differentiation. To mimic a local tumour microenvironment, human PBMCs were exposed to conditioned medium (CM) from BxPC-3 human pancreatic cancer cells cultured in different glucose conditions. CM from BxPC-3 induced a strong enrichment of a population enlarged cells with ruffling membranes, based on the flow cytometry scatter profile (Fig. 1a ).
This tumour-educated population accounted for 8-18% of the total PBMCs compared to 4% in naïve control cells. Over time, the tumour-educated cell population was better maintained and more numerous in the presence of high (25 mM) compared to normal (5 mM) glucose levels (Fig. 1b) . The tumour-educated population was found to be CD68 positive, indicating the cells to be of the monocyte-macrophage lineage (Fig. 1c) . In addition, exposure to BxPC-3 CM stimulated a significant increase in IL-6 and IL-8 cytokine levels (Fig. 1d) . The cytokine levels were further enhanced in hyperglycaemic conditions, resulting in an almost 3-and 2-fold increase in IL-6 and IL-8 levels, respectively, compared to normal glucose conditions. which further verified them to be of the monocyte-macrophage lineage. The cell surface levels of the TLR4 co-receptor CD14 were enhanced among tumour-educated macrophages exposed to high (25 mM) relative to normal (5 mM) glucose levels (N.S.; Fig. 2b ). The CD14 + HLA-DR + population was further analysed for CD11c and CD206 positivity (Fig. 2c) .
Initially, the majority of cells were CD11c + CD206 -. However, the CD206 levels increased over time and after 72 h differentiation, more than 90% of the macrophages were 
Hyperglycaemia enhances the cytokine secretion in response to LPS
In order to determine the activation status of the BxPC-3 tumour-educated macrophage population in the PBMCs, their functional responsiveness to the TLR4 agonist LPS at different glucose levels was examined. Exposure to LPS significantly increased the IL-1β, IL-6, IL-8 and IL-10 cytokine levels (P<0.001; Fig. 3a-d) . Hyperglycaemic conditions further enhanced the LPS-induced IL-6 and IL-8 levels, while no obvious influence on IL-1β and IL-10 levels was observed. In contrast, LPS-stimulation strongly promoted TNF-α release by naïve control cells, which was not further altered in the presence of BxPC-3 CM or hyperglycaemia (Fig. 3e) . No effect by LPS on macrophage enrichment or polarization was observed (data not shown).
The macrophage enrichment and associated cytokine secretion is suppressed by metformin
The anti-diabetic drug metformin has been reported to alter inflammatory signatures. Hence, we next investigated the influence by metformin on the tumour-induced macrophage differentiation. Exposure to metformin impaired the responsiveness to BxPC-3 CM differentiating activity and significantly reduced the tumour-educated macrophage population with up to 51% in normal glucose ( Fig. 4a-b) . Similarly, the tumour-educated macrophage population was reduced after exposure to metformin in hyperglycaemic conditions, although a significantly higher frequency of macrophages remained after the longest exposure time (P<0.05; Fig. 4b ). In addition, the associated IL-6 and IL-8 levels were significantly suppressed for the tumour-educated cells exposed to metformin, at both normal and high glucose concentrations (P<0.01; Fig. 4c ). Notably, the cytokine reduction was more pronounced than the reduction in macrophage frequency. This indicates that metformin suppressed both the frequency as well as the activation state of the tumour-educated macrophages.
Metformin attenuates the tumour-educated macrophage polarisation
Having found that metformin suppressed the tumour-educated macrophage frequency, we further assessed its effect on the phenotype polarization. Exposure to metformin resulted in a pronounced decrease in CD14 positivity, while no apparent change in HLA-DR expression was observed (Fig. 5a ). In addition, metformin counteracted the BxPC-3 CM induced CD206
expression. After 24 and 72 h culture, the geometric mean fluorescence intensity (geo-MFI) of CD206 was 30-40% lower for metformin-treated compared to non-treated cells (P<0.05; Fig. 5b-c). The reduced CD206 levels resulted in a shifted phenotype balance with re-polarization towards CD11c + CD206 -cells, which was further emphasized at hyperglycaemic conditions ( Fig. 5d ).
Metformin suppresses LPS responsiveness and cytokine secretion
To assess the relevance of losing the TLR4 co-receptor CD14 expression and altering the phenotype polarization of the tumour-educated macrophage population, we evaluated the impact of metformin on the functional responsiveness to LPS. Indeed, the sensitivity to the TNFα secretion to almost undetectable levels at both normal and high glucose levels ( Fig. 6e ).
These results indicate that the sensitivity to tumour-induced macrophage differentiation and functionality was impaired in the presence of metformin.
Tumour-educated macrophages and hyperglycaemia promote invasion of pancreatic cancer cells
Finally, a direct functional effect of the tumour-educated macrophages and hyperglycaemia on pancreatic cancer cell invasion was determined. BxPC-3 cells co-cultured with PBMCs displayed significantly higher invasive capabilities than BxPC-3 cells cultured alone, in accordance with the tumour-promoting role of TAMs (P<0.001; Fig. 7a-b Previous studies on pancreatic cancer-related inflammation have shown enhanced leukocyte infiltration in the tumour microenvironment and elevated systemic cytokine levels in patients with pancreatic cancer [26] [27] [28] [29] [30] . Macrophages, in particular with an alternatively activated M2-associated phenotype, were among the most common leukocyte subsets infiltrating the tumour area 29, 30 . This was further reflected in the systemic cytokine levels, where IL-6, IL-8 and IL-10 were elevated in pancreatic cancer patients [26] [27] [28] . In addition, a recent in vivo study showed that macrophages infiltrated the pancreatic tumour already at the early pre-invasive stages and remained one of the dominating leukocytes throughout the pathogenesis of the disease 31 . This
indicates an important role of tumour-associated macrophages in pancreatic tumourigenesis.
Due to the high plasticity of macrophages, the M1/M2 paradigm is debated and has recently been regarded an oversimplified view and extreme ends of a spectrum of phenotype which was believed to be mediated by M-CSF secreted by the cancer cells 35 . The TAMs were found to secrete both M1 (TNFα) and M2-associated (IL-10, IL-6 and CCL2) cytokines.
While promoting macrophage enrichment, pancreatic cancer cells have been shown to inhibit dendritic cells differentiation via secretion of IL-6 and G-CSF 36 .
A primary function of macrophages is to rapidly increase cytokine and chemokine biosynthesis and release upon activation by different TLRs 17 . Interestingly, the TLR4 coreceptor CD14 was upregulated on the tumour-educated macrophages under hyperglycaemic conditions that may influence the TAM activation and sensitivity to LPS stimulation. A study investigating the LPS/NFκB-pathways in TAMs demonstrated that TAMs accumulate inhibitory p50 homodimers of NFκB in the nucleus, which alters the TAMs classic response to LPS and leads to a reduced TNFα secretion 37 . In the present study, elevated levels of IL-1β, IL-6, IL-8 and IL-10 were seen in response to LPS. In contrast, no increase in TNFα was observed by TAMs compared to basal levels of naïve cells. This is in line with the M2-like phenotype previously described for TAMs, and the indications of an altered LPS response.
The glucose-lowering drug metformin is used as first-line treatment in the management of type 2 diabetes. It has recently been shown to have anti-tumour properties, besides its antidiabetic effects 23 . In addition, metformin has been indicated to have anti-inflammatory effects by indirect inhibition of inflammatory mechanisms 24, 25 . In the present study, metformin effectively suppressed the macrophage enrichment, phenotype polarisation and cytokine secretion regardless of the glucose levels. Metformin also strongly reduced cytokine secretion induced by LPS, which further supports its implied anti-inflammatory effects. Metformin might therefore have a wider range of action than the initial anti-diabetic, and later antitumour, effects seen.
TAMs have several roles in the tumour microenvironment where they stimulate migration, invasion and metastatic abilities [18] [19] [20] . We found that BxPC-3 pancreatic cancer cells displayed an enhanced motility after co-culture with tumour-educated macrophages. In addition, we made the novel observation that these invasive capabilities were further emphasized in the presence of hyperglycaemia. In previous studies with colon cancer 38 and pancreatic cancer cells 39 , co-culture with monocytes or macrophages increased the cancer cell migration rate via paracrine mechanisms involving SDF-1α, VEGF and TNFα. Consistent with our findings, hyperglycaemia alone, without the influence of TAMs, increased the pancreatic cancer cell proliferation and migration 40 . However, our study has uniquely shown the combined influence of leukocytes and glucose on pancreatic cancer cell motility. While metformin influenced the macrophage phenotype under both glucose conditions, the inhibitory effect by metformin on the pancreatic cancer cell invasiveness was strongly reduced or abolished in the presence of high glucose. This may relate to an altered communication between the macrophages and cancer cells, while more likely to an altered responsiveness by the pancreatic cancer cells to metformin under hyperglycaemic conditions, as previously reported 23 .
In 
Cell culture
The human pancreatic adenocarcinoma cell lines BxPC-3, PANC-1, MIAPaCa-2 were purchased from ATCC-LGC Standards (Manassas, VA, USA). The cells were maintained in RPMI1640 or DMEM supplemented with 10% FBS and antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin) in a humified 5% CO 2 atmosphere at 37 o C. All experiments were performed in glucose-free RPMI1640 or DMEM supplemented with 5 mM (normal) or 25 mM (high) D-glucose, 2 mM L-glutamine and antibiotics as above (serum free media; SFM).
Conditioned medium (CM) was obtained by culturing BxPC-3 cells to 70-80% confluence, washing twice and changing to SFM. CM was collected after 48 h incubation, residual cells removed by centrifugation, and aliquots stored at -80 o C until further use. 
In vitro macrophage differentiation
LPS stimulation of in vitro differentiated macrophages
PBMCs were seeded (5 x 10 5 cells/well) in 6-well plates with SFM or CM, with or without 20 mM metformin, and incubated for 72 h. LPS (100 ng/ml) was spiked into the cell cultures during the last 24 h of incubation. Cells were analysed by flow cytometry as above and supernatants collected and stored for ELISA.
Enzyme-linked immunosorbent assay (ELISA)
Cytokine levels of cell supernatants were assessed using DuoSet ELISA according to the manufacturer's instructions (R&D systems, Abingdon, UK). Samples were measured in duplicate on a Labsystems Multiskan Plus plate reader (test wavelength 450 nm, reference wavelength 540 nm) using the DeltaSoft JV software (BioMetallics Inc., Princeton, NJ, USA).
Assay sensitivities for the analytes were: IL-1β (3.91 pg/ml), IL-6 (9.38 pg/ml), IL-8 (31.25 pg/ml), IL-10 (31.25 pg/ml), and TNFα (15.63 pg/ml).
Invasion studies
PBMCs ( 
